Skip to main content

Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis

World Journal of Urology volume 25, pages 315–323 (2007)Cite this article

Abstract

Investigations in healthy persons have shown that drinking mineral water containing HCO3 has a positive effect on urine supersaturated with calcium oxalate (SSCaOx). The present study evaluates in a common setting whether these effects are also relevant in patients with multiepisodic urinary stone formation. A total of 34 patients with evident multiepisodic CaOx-urolithiasis were included in the study. Patients with hyperparathyroidism, renal tubular acidosis, Wilson’s disease, Cushing disease, osteoporosis and malignant diseases were excluded. In a cross-over design and double-blinded the patients received 1.5 l of a mineral water with 2.673 mg HCO3/l (test water) or the same amount of water with a low mineral content (98 mg HCO3/l) (control water) daily for 3 days. During the study period the patients diet was recorded in a protocol, but not standardised. The main target parameter was SSCaOx in 24 h urine. In addition, urinary pH and the most important inhibiting and promoting factors were measured in 24 h urine (Ca, Ox, Mg, Cit). Both waters tested led to a highly significant increase in 24 h urine volume without a difference between each other. In the group, drinking the water containing HCO3 the urinary pH increased significantly and was within a range relevant for metaphylaxis of calcium oxalate stone formation (x = 6.73). This change was highly significant compared to the control group. In addition, significantly increased magnesium and citrate concentration were also observed. Supersaturation with calcium oxalate decreased significantly and to a relevant extent; however, there was no difference between the waters tested. As expected, the risk of uric acid precipitation also decreased significantly under bicarbonate water intake. However, an increase of the risk of calcium phosphate stone formation was observed. It is evident that both waters tested are able to lower significantly and to a relevant extent the risk of urinary stone formation in patients with multiepisodic CaOx-urolithiasis. In addition, the bicarbonate water increases the inhibitory factors citrate and magnesium due to its content of HCO3 and Mg. Thus, it can be recommended for metaphylaxis of calcium oxalate and uric acid urinary stones.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Achilles W, Ulshöfer B (1985) Calculation of complex chemical equilibria in urine: estimation of the risk of stone formation and derivation of prophylactic measures. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum, New York pp 777–780

    Google Scholar 

  2. Ackermann D (1997) Empfehlungen zur Harnsteinmetaphylaxe-Kurzfassung für die tägliche Praxis. Urologe A 36:231–232

    PubMed  CAS  Article  Google Scholar 

  3. Anderson RA (2002) A complementary approach to urolithiasis prevention. World J Urol 20:294–301

    PubMed  Google Scholar 

  4. Böhmer I, Hesse A, Vahlensieck W (1985) Welchen Einfluss hat der Kalzium-Magnesium- und Natrium-Gehalt von Mineralwässern auf die Harnzusammensetzung? In: Gasser G, Vahlensieck W (eds). Pathogenese und Klinik der Harnsteine XI. Steinkopff, Darmstadt pp 160–173

    Google Scholar 

  5. Butz M (1982) Oxalatsteinprophylaxe durch Alkali-Therapie. Urologe A 21:142–146

    PubMed  CAS  Google Scholar 

  6. Butz M (1989) Zitrat und Kalziumurolithiasis. Perimed-Fachbuch-Verlagsgesellschaft GmbH, Erlangen

  7. Caudarella R, Rizzoli E, Buffa A, Bottura A, Steffoni S (1998) Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol 159:658–663

    PubMed  CAS  Article  Google Scholar 

  8. Finlayson B (1977) Calcium stones: same physical and clinical aspectes. In: David DS (ed) Calcium metabolism in renal failure and nephrolithiasis. Wiley, New York pp 337–382

    Google Scholar 

  9. Ganter K, Winter P, Brockhaus S, Hesse A (1996) Alkalisierung des Harns zur Metaphylaxe bei Kalziumoxalatsteinleiden K-Zitrat vs. Na-K-Zitrat. Urologe B 36:461–465

    Article  Google Scholar 

  10. Gilsdorf K, Gutenbrunner Chr (1987) Untersuchungen über den Einfluss calciumhaltiger Mineralwässer auf die Übersättigung des Harnes an Calciumoxalat. Z Phys Med 16:318–319

    Google Scholar 

  11. Grizzle JE (1965) The two-period change-over design and its use in clinical trials. Biometrics 21:467–480

    PubMed  CAS  Article  Google Scholar 

  12. Gundermann G, Hoffmann H, Gutenbrunner Chr (2004) Trinken—aber was? Heilwässer in der Harnsteinmetaphylaxe. Ernähr Med 19:178–183

    CAS  Article  Google Scholar 

  13. Gutenbrunner Chr (1984) Zur Methodik der Prüfung von Wirkung und Wirksamkeit der Heilwasser-Trinkkuren. Ärztez Naturheilverfahr Regulationsmed 25:16–32

    Google Scholar 

  14. Gutenbrunner Chr (1988) Die Bedeutung von Trinkkuren bei der Harnsteinmetaphylaxe. Therapiewoche 38:1605–1615

    Google Scholar 

  15. Gutenbrunner Chr, Gilsdorf K, Hildebrandt G (1989) Untersuchungen über den Einfluß kalziumhaltiger Mineralwässer auf die Übersättigung des Harnes mit Kalziumoxalat. Urologe A 28:15–19

    Google Scholar 

  16. Gutenbrunner Chr, Hildebrandt G (1994) Handbuch der Heilwasser-Trinkkuren: Theorie und Praxis. Johannes Sonntag Verlagsbuchhandlung GmbH, Stuttgart

    Google Scholar 

  17. Gutenbrunner Chr, Hildebrandt G (1998) Handbuch der Balneologie und medizinischen Klimatologie. Springer, Berlin

    Google Scholar 

  18. Hecker H (1986) Identification and interpretation of effects in two-period cross-over designs. EDV Med Biol 17:60–66

    Google Scholar 

  19. Hess B (2003) Pathophysiologie, Diagnostik und konservative Therapie bei Kalzium-Nierensteinen. Ther Umsch 60:79–87

    PubMed  CAS  Article  Google Scholar 

  20. Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44:709–713

    PubMed  CAS  Article  Google Scholar 

  21. Hesse A, Jahnen A, Klocke K, Nolde A, Scharrel O (1994) Nachsorge bei Harnstein-Patienten. Ein Leitfaden für die ärztliche Praxis. Gustav Fischer Verlag, Jena

    Google Scholar 

  22. Hesse A, Jöge S, Jahnen A, Schmitz W, Klocke K (1993) Anwendung von Natriumhydrogenkarbonat zur Alkalisierungstherapie bei Kalziumoxalatsteinpatienten. Urologe B 33:160–163

    Google Scholar 

  23. Hesse A, Siener R (1997) Current aspects of epidemiology and nutrition in urinary stone disease. World J Urol 15:165–171

    PubMed  CAS  Article  Google Scholar 

  24. Hesse A, Tiselius HG, Jahnen A (2002) Urinary stones: diagnosis, treatment and prevention of recurrence 2nd edn. Karger, Basel

    Google Scholar 

  25. Hills M, Armitage P (1979) The two-period cross-over clinical trial. Br J Clin Pharmacol 8:7–20

    PubMed  CAS  Google Scholar 

  26. Karagülle O, Kleczka T, Vidal C, Candir F, Gundermann G, Külpmann WR, Gehrke A, Gutenbrunner C (2006) Magnesium absorption from mineral waters of different magnesium content in healthy subjects. Forsch Komplementärmed 13:9–14

    PubMed  Article  Google Scholar 

  27. Kessler T, Hesse A (1998) Harnsäure-und Kalziumoxalatsteinmetaphylaxe mit natriumbikarbonathaltigem Heilwasser. Urologe B 38:363–369

    Article  Google Scholar 

  28. Kessler T, Hesse A (2000) Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy male subjects. Br J Nutr 84:856–871

    Google Scholar 

  29. Lee YH, Huang WC, Tsai JY, Huang JK (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 161:1453–1457

    PubMed  CAS  Article  Google Scholar 

  30. Leumann E, Hoppe B, Neuhaus T, Blau N (1995) Efficacy of oral citrate administration in primary hyperoxaluria. Nephrol Dial Transplant 10(Suppl 8):14–16

    PubMed  Google Scholar 

  31. Lux B, Braun J, May P (1982) Purinbelastungstest bei Calcium-Oxalat-Steinbildnern. Urologe A 21:147–149

    PubMed  CAS  Google Scholar 

  32. Marangella M, Vitale C, Petrarulo M, Rovera L, Dutto F (1996) Effects of mineral composition of drinking water on risk for stone formation and bone metabolism in idiopathic calcium nephrolithiasis. Clin Sci 91:313–318

    PubMed  CAS  Google Scholar 

  33. Müller SC, Hofmann R, Köhrmann KU, Hesse A (2004) Epidemiologie, instrumentelle Therapie und Metaphylaxe des Harnsteinleidens. Dtsch Ärztebl Jg101.19:1101–1106

    Google Scholar 

  34. Pak CY, Poindexer JR, Peterson RD, Koska J, Sakhaee K (2002) Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology 60:789–794

    PubMed  Article  Google Scholar 

  35. Reinecke F, Maack J (1981) Die Prophylaxe der rezidivierenden Oxalatsteine mit Allopurinol. Therapiewoche 31:1325–1326

    Google Scholar 

  36. Rodgers AL (1997) Effect of mineral water containinig calcium and magnesium on calcium oxalate urolithiasis risk factors. Urol Int 58:93–99

    PubMed  CAS  Article  Google Scholar 

  37. Sakhaee K, Nicar M, Hill K, Pak CY (1983) Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and cristallization of stone forming salts. Kidney Int 24:348–352

    PubMed  CAS  Google Scholar 

  38. Serio A, Fraioli A (1999) Epidemiology of Nephrolothiasis. Nephron 81(Suppl 1):26–30

    PubMed  Article  Google Scholar 

  39. Siener R, Jahnen A, Hesse A (2004) Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr 58:270–276

    PubMed  CAS  Article  Google Scholar 

  40. Smorag U, Karagülle O, Gundermann G, Becker AJ, Jonas U, Gehrke A, Gutenbrunner Chr (2005) Sind Heilwässer in der Metaphylaxe der Urolithiasis auch bei Patienten mit Hyperkalziurie oder Hyperoxalurie geeignet? Phys Med Rehab Kuror 15:262

    Google Scholar 

  41. Strohmaier WL (2000) Volkswirtschaftliche Aspekte des Harnsteinleidens und der Harnsteinmetaphylaxe. Urologe A 39:166–170

    PubMed  CAS  Article  Google Scholar 

  42. Tiselius HG (1997) Risk formulas in calcium oxalate urolithiasis. World J Urol 15:176–185

    PubMed  CAS  Article  Google Scholar 

  43. Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Galluci M (2001) Guidelines on Urolithiasis. Eur Urol 40:362–371

    PubMed  CAS  Article  Google Scholar 

  44. Ulshöfer B, Naber K, Achilles W, Rohani AM (1985) Der Einfluß des Kalziumgehaltes verschiedener Wässer auf die Kalziumausscheidung und das Steinbildungsrisiko. In: Gasser G, Vahlensieck W (eds) Pathogenese und Klinik der Harnsteine XI. Steinkopff, Darmstadt pp 174–179

    Google Scholar 

  45. Wagenknecht LV, Lotzin CF, Napp R, Freerksen E (1981) Steinprophylaktische Elektrobalance unter stationären Bedingungen. Therapiewoche 31:1314–1318

    Google Scholar 

  46. Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL 2: a basic computer program for the calculation of urinary saturation. J Urol 143:1242–1244

    Google Scholar 

  47. www.bundesaerztekammer.de/30/versorgungsforschung/10Definition/

Download references

Author information

Affiliations

  1. Institute of Balneology and Medical Climatology, Department of Physical Medicine and Rehabilitation, Medical School of Hanover, Carl-Neuberg-Str. 1, 30625, Hanover, Germany

    O. Karagülle, F. Candir & C. Gutenbrunner

  2. Institute of Rehabilitation Medicine and Balneology, Bad Wildungen, Germany

    O. Karagülle, G. Gundermann & C. Gutenbrunner

  3. Department of Urology, Medical School of Hanover, Hanover, Germany

    U. Jonas

  4. Department of Urology, Ludwig-Maximilians University, Munich, Germany

    A. J. Becker

  5. Department of Physical Medicine and Rehabilitation, Medical School of Hanover, Hanover, Germany

    U. Smorag & A. Gehrke

Authors
  1. O. Karagülle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Smorag
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Candir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Gundermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. Jonas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. J. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Gehrke
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Gutenbrunner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. Karagülle.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Karagülle, O., Smorag, U., Candir, F. et al. Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis. World J Urol 25, 315–323 (2007). https://doi.org/10.1007/s00345-007-0144-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-007-0144-0

Keywords

  • Metaphylaxis
  • CaOx-urolithiasis
  • Mineral water
  • Bicarbonate
  • Supersaturation